219 related articles for article (PubMed ID: 25124043)
21. Post-transcriptional regulation of glucose transporter-1 by an AU-rich element in the 3'UTR and by hnRNP A2.
Griffin ME; Hamilton BJ; Roy KM; Du M; Willson AM; Keenan BJ; Wang XW; Nichols RC
Biochem Biophys Res Commun; 2004 Jun; 318(4):977-82. PubMed ID: 15147968
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
Peebles KA; Dwyer-Nield LD; Malkinson AM
Mol Carcinog; 2007 Nov; 46(11):887-900. PubMed ID: 17477362
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase.
Arvidsson Y; Sumantran V; Watt F; Uramoto H; Funa K
Pediatr Blood Cancer; 2005 Jan; 44(1):77-84. PubMed ID: 15390277
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways.
Liu Y; Li H; Liu F; Gao LB; Han R; Chen C; Ding X; Li S; Lu K; Yang L; Tian HM; Chen BB; Li X; Xu DH; Deng XL; Shi SL
EBioMedicine; 2020 Jan; 51():102583. PubMed ID: 31901866
[TBL] [Abstract][Full Text] [Related]
25. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
[TBL] [Abstract][Full Text] [Related]
26. Histochemical mapping of hnRNP A2/B1 in rat brain after ischemia-reperfusion insults.
Liu Y; Gao Y; Wu Y; Wu Y; Wang H; Zhang C
J Histochem Cytochem; 2010 Aug; 58(8):695-705. PubMed ID: 20421594
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
Cui H; Wu F; Sun Y; Fan G; Wang Q
BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
[TBL] [Abstract][Full Text] [Related]
28. Emergence of heterogeneous nuclear ribonucleoprotein A2/B1 vs loss of E-cadherin: their reciprocal immunoexpression profiles in human pancreatic cancer.
Gu W; Liu W; Shen X; Shi Y; Wang L; Liu H
Ann Diagn Pathol; 2013 Feb; 17(1):14-7. PubMed ID: 22622045
[TBL] [Abstract][Full Text] [Related]
29. Gene trap mutagenesis of hnRNP A2/B1: a cryptic 3' splice site in the neomycin resistance gene allows continued expression of the disrupted cellular gene.
Roshon M; DeGregori JV; Ruley HE
BMC Genomics; 2003 Jan; 4(1):2. PubMed ID: 12546712
[TBL] [Abstract][Full Text] [Related]
30. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
31. hnRNP A2/B1 interacts with influenza A viral protein NS1 and inhibits virus replication potentially through suppressing NS1 RNA/protein levels and NS1 mRNA nuclear export.
Wang Y; Zhou J; Du Y
Virology; 2014 Jan; 449():53-61. PubMed ID: 24418537
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneous nuclear ribonucleoprotein (hnRNP) F is a novel component of oligodendroglial RNA transport granules contributing to regulation of myelin basic protein (MBP) synthesis.
White R; Gonsior C; Bauer NM; Krämer-Albers EM; Luhmann HJ; Trotter J
J Biol Chem; 2012 Jan; 287(3):1742-54. PubMed ID: 22128153
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.
Zhou J; Allred DC; Avis I; Martínez A; Vos MD; Smith L; Treston AM; Mulshine JL
Breast Cancer Res Treat; 2001 Apr; 66(3):217-24. PubMed ID: 11510693
[TBL] [Abstract][Full Text] [Related]
34. The discoidin domain receptor 1 gene has a functional A2RE sequence.
Roig B; Moyano S; Martorell L; Costas J; Vilella E
J Neurochem; 2012 Feb; 120(3):408-18. PubMed ID: 22077590
[TBL] [Abstract][Full Text] [Related]
35. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.
Zhou J; Nong L; Wloch M; Cantor A; Mulshine JL; Tockman MS
Lung Cancer; 2001 Dec; 34(3):341-50. PubMed ID: 11714531
[TBL] [Abstract][Full Text] [Related]
36. [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].
Li F; Zhong Z; Li R; Huang H; Wang L; Zheng D; Zhang D
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):317-21. PubMed ID: 20677557
[TBL] [Abstract][Full Text] [Related]
37. HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression.
Hu T; Zeng C; Song Z; Liu Q; Chen S; Huang W; Ma Q; Li H
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167050. PubMed ID: 38331110
[TBL] [Abstract][Full Text] [Related]
38. Testis- and developmental stage-specific expression of hnRNP A2/B1 splicing isoforms, B0a/b.
Matsui M; Horiguchi H; Kamma H; Fujiwara M; Ohtsubo R; Ogata T
Biochim Biophys Acta; 2000 Sep; 1493(1-2):33-40. PubMed ID: 10978504
[TBL] [Abstract][Full Text] [Related]
39. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
[TBL] [Abstract][Full Text] [Related]
40. The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression.
Pioli PA; Rigby WF
J Biol Chem; 2001 Oct; 276(43):40346-52. PubMed ID: 11517223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
